Home

Life Sciences BC 2025-26 Board of Directors Announcement

Life Sciences BC (LSBC) is pleased to announce new and returning members to the Board of Directors following its Annual General Meeting (AGM) on September 17, 2025. The Board of Directors is comprised of seasoned leaders dedicated to driving forward the growth of the life sciences sector.

New and Returning Board Members and Observers

LSBC welcomes Christina Zacharuk, CEO of Research Universities’ Council of British Columbia, and Sandra Wong, Senior Manager, Access and Government Affairs of Pfizer Canada, who were each elected to three-year terms.

Anne Stevens, VP Business Development of AbCellera, Michael Martin, Global Biopharmaceutical Executive, and Suzanne Gill, President & CEO of Genome British Columbia, were each re-elected to three-year terms.

At the Board Meeting following the AGM, Hector MacKay-Dunn, KC, Joseph Garcia, and Roger Kuypers received renewed one-year appointments as Board Observers.

The full slate of LSBC’s Board of Directors is listed below. To learn more about our current board members, please visit our website: https://lifesciencesbc.ca/about-us/board-directors/

LSBC Board Directors – Executive Committee

  • Chair: Anne Stevens, VP Business Development, AbCellera
  • Vice-Chair: Lana Janes, Co-Founder & COO, Abdera Therapeutics
  • Treasurer: Rajveer Hundal, Partner, PWC Canada

LSBC Board Directors

  • Ali Ardakani, Founder & Managing Director, Novateur Ventures, Co-Founder & CEO of Optigo Biotherapeutics
  • Sherry Aulin, Life Sciences Executive Leader (former CFO Xenon)
  • Kevin Chaplin, CEO, Kardium
  • Tom Frohlich, CEO, Jade Biosciences
  • Suzanne Gill, President & CEO of Genome British Columbia
  • David Helliwell, Co-Founder & Executive Board Chair, Thrive Health
  • Wendy Hurlburt, President & CEO, Life Sciences BC
  • Michael Martin, Global Biopharmaceutical Executive
  • Scott Phillips, President, Starfish Medical
  • David Poon, Co-Founder, Head of Corporate Development, DCx
  • Sandra Wong, Senior Manager, Access and Government Affairs, Pfizer Canada
  • Christina Zacharuk, CEO of Research Universities’ Council of British Columbia
  • Peter Zandstra, Professor & Director, UBC School of Biomedical Engineering

LSBC Board Observers

  • Joseph Garcia, Partner, Blake, Cassels & Graydon LLP
  • Roger Kuypers, Partner, Fasken, Martineau, Dumoulin LLP
  • Hector MacKay-Dunn, KC, Senior Partner, Farris, Vaughan, Wills & Murphy LLP

Past Board Members

LSBC would like to thank our outgoing Board Directors for their service and leadership over the past years.

  • Max Blouw, Former President, Research Universities Council of BC,

    LSBC Board Director for 4 years
  • Bev Holmes, President & CEO, Health Research BC,

    LSBC Board Director for 3 years
  • David Llewellyn, President and CEO, Trailhead Biosystems,

    LSBC Board Director for 7 years

About Life Sciences BC

Life Sciences BC (LSBC) is a not-for-profit sector association dedicated to advancing British Columbia’s life sciences ecosystem through strategic initiatives at the local, national, and international levels. We drive economic growth in the province by providing leadership, fostering investment and partnerships, collaborating with government, and promoting BC’s world-class life sciences sector.

Contacts